Elixir Medical's third first-in-man study of a myolimus-eluting coronary stent with a biodegradable polymer coating.
Phase of Trial: Phase I
Latest Information Update: 18 May 2012
At a glance
- Drugs Myolimus (Primary)
- Indications Coronary artery disease; Coronary artery restenosis
- Focus Adverse reactions; Therapeutic Use
- 18 May 2012 New trial record